Structure Therapeutics Stock Forecast - Period Momentum Indicator

GPCR Stock   34.01  0.60  1.80%   
Structure Stock Forecast is based on your current time horizon. Although Structure Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Structure Therapeutics' systematic risk associated with finding meaningful patterns of Structure Therapeutics fundamentals over time.
  
As of 11/26/2024, Payables Turnover is likely to grow to 0.21. As of 11/26/2024, Common Stock Shares Outstanding is likely to grow to about 40.3 M, while Net Loss is likely to drop (41.4 M).
Structure Therapeutics American has current Period Momentum Indicator of 0.6. Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check Structure Therapeutics VolatilityBacktest Structure TherapeuticsInformation Ratio  

Structure Therapeutics Trading Date Momentum

On November 25 2024 Structure Therapeutics American was traded for  34.01  at the closing time. The top price for the day was 34.53  and the lowest listed price was  33.40 . The trading volume for the day was 955.3 K. The trading history from November 25, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 1.00% .
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Structure Therapeutics to competition

Other Forecasting Options for Structure Therapeutics

For every potential investor in Structure, whether a beginner or expert, Structure Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Structure Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Structure. Basic forecasting techniques help filter out the noise by identifying Structure Therapeutics' price trends.

Structure Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Structure Therapeutics stock to make a market-neutral strategy. Peer analysis of Structure Therapeutics could also be used in its relative valuation, which is a method of valuing Structure Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Structure Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Structure Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Structure Therapeutics' current price.

Structure Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Structure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Structure Therapeutics shares will generate the highest return on investment. By undertsting and applying Structure Therapeutics stock market strength indicators, traders can identify Structure Therapeutics American entry and exit signals to maximize returns.

Structure Therapeutics Risk Indicators

The analysis of Structure Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Structure Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting structure stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Structure Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Structure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Structure Stock

  0.65A Agilent TechnologiesPairCorr
  0.72ME 23Andme HoldingPairCorr

Moving against Structure Stock

  0.47MDGL Madrigal PharmaceuticalsPairCorr
  0.45KEP Korea Electric PowerPairCorr
  0.38RNXT RenovoRxPairCorr
The ability to find closely correlated positions to Structure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Structure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Structure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Structure Therapeutics American to buy it.
The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Structure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Structure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Structure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Structure Stock Analysis

When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.